J. Nørdling
About
In The Last Decade
J. Nørdling
95 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 108
- Urology 2.1k
- Rheumatology 1.4k
- Pulmonary and Respiratory Medicine 862
- Epidemiology 532
- Surgery 444
Countries citing papers authored by J. Nørdling
This map shows the geographic impact of J. Nørdling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Nørdling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Nørdling more than expected).
Fields of papers citing papers by J. Nørdling
This network shows the impact of papers produced by J. Nørdling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Nørdling. The network helps show where J. Nørdling may publish in the future.
Co-authorship network of co-authors of J. Nørdling
This figure shows the co-authorship network connecting the top 25 collaborators of J. Nørdling. A scholar is included among the top collaborators of J. Nørdling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Nørdling. J. Nørdling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 12 | |
| 2 | 24 | |
| 3 | 2 | |
| 4 | 69 | |
| 5 | 31 | |
| 6 | 3 | |
| 7 | BPH: a progressive disease of the ageing male | 3 |
| 8 | 29 | |
| 9 | 4 | |
| 10 | 11 | |
| 11 | 22 | |
| 12 | Tamsulosin, the first prostate-selective alpha 1A-adrenoceptor antagonist. A meta-analysis of two randomized, placebo-controlled, multicentre studies in patients with benign prostatic obstruction (symptomatic BPH). European Tamsulosin Study Group. | 197 |
| 13 | 16 | |
| 14 | 6 | |
| 15 | 29 | |
| 16 | 5 | |
| 17 | 13 | |
| 18 | 62 | |
| 19 | 146 | |
| 20 | 7 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.